Journal Information
Vol. 46. Issue 4.
Pages 165-175 (April 2010)
Share
Share
Download PDF
More article options
Vol. 46. Issue 4.
Pages 165-175 (April 2010)
Original Article
Full text access
Validation of the Spanish Version of the Revised Cystic Fibrosis Quality of Life Questionnaire in Adolescents and Adults (CFQR 14+ Spain)
Validación de la versión española del cuestionario revisado de calidad de vida para fibrosis quística en adolescentes y adultos (CFQR 14+ Spain)
Visits
6484
Gabriel Olveiraa,b, Casilda Olveirac,
Corresponding author
casi1547@separ.es

Corresponding author.
, Inmaculada Gaspard, Ivette Cruze, Antonio Doradoc, Estela Pérez-Ruizf, Nuria Porrasa, Federico Soriguera,b
a Unidad de Fibrosis Quística, Servicio de Endocrinología y Nutrición, Hospital Regional Universitario Carlos Haya, Málaga, Spain
b CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
c Unidad de Fibrosis Quística, Servicio de Neumología, Hospital Regional Universitario Carlos Haya, Málaga, Spain
d Servicio de Neumología, Hospital Costa del Sol, Marbella, Málaga, Spain
e Departments of Psychology and Pediatrics, University of Miami, United States, Málaga, Spain
f Unidad de Fibrosis Quística, Servicio de Pediatría, Hospital Regional Universitario Carlos Haya, Málaga, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Background

The aim of this study was to assess the validity and reliability of the Spanish version of the revised disease-specific health related quality of life questionnaire for adolescents and adults with cystic fibrosis (CFQR 14+ Spain).

Patients and methods

A total of 43 cystic fibrosis (CF) patients completed the CFQR 14+ Spain. Forced expiratory volume in 1 second, in percentage of predicted - FEV1 (%) -, number of respiratory exacerbations, 6-minute walk test, Bhalla score (based on computerized tomography of the chest), fat-free mass index, body mass index (BMI), faecal fat and St George's Respiratory Questionnaire were included as measurements of health status.

Results

Ten out of the twelve scales had alpha coefficients above 0.70. Test-retest correlations (Spearman) ranged from 0.49 to 0.95 and they were significant in all scales. Intraclass correlations ranged from 0.47 to 0.95 (ten out of the twelve scales were >0.70) forty out of the fifty items have correlations between items and scale above 0.70. All the CFQR 14+ scales, except the digestive symptoms scale, discriminated significantly between patients with mild, moderate and severe disease (according to FEV1 [%]). Other respiratory parameters also discriminated significantly between patients with mild-moderate and severe disease. Only some scales discriminated significantly between nourished and malnourished patients. All of the scales met standards for floor effects (<15% of the responders with the lowest score) but not for ceiling effects (only five out of the twelve).

Conclusion

The Spanish CFQR 14+ (Spain) is a reliable and valid instrument for measuring the health-related quality of life in Spanish adolescents and adults with CF, though with the exception of a few of its subscales.

Keywords:
Cystic fibrosis
Cystic fibrosis quality of life questionnaire
CFQR 14+ Spain
Lung function
Pulmonary exacerbations
6-minute walk test
Computerized tomography of the chest
Body mass index
Fat-free mass index
Diabetes
Resumen
Objetivos

Estudiar la validez y fiabilidad de la versión española del cuestionario revisado de calidad de vida para fibrosis quística (FQ) en adolescentes y adultos (CFQR 14+ Spain).

Pacientes y métodos

Se estudiaron 43 adolescentes y adultos con FQ, clínicamente estables. Se utilizaron como medidas del estado de salud parámetros radiológicos, espirométricos, número de reagudizaciones, prueba de la marcha de 6 min, antropométricos (índice de masa corporal, desnutrición de masa magra), grasa en heces y el cuestionario respiratorio de St. George (SGRQ).

Resultados

El alfa de Cronbach fue ≥0,70 para todas las escalas, excepto para «síntomas digestivos» y «carga de tratamiento». Cuarenta ítems (de 50) presentaron correlaciones ítems-escala mayores a 0,70 y el 98% mayores a 0,40. La reproductibilidad test-retest (coeficiente de Spearman) osciló entre 0,49-0,95 y el coeficiente de correlación intraclase alcanzó puntuaciones mayores de 0,70 en 10 de 12 escalas. Todas las dimensiones correlacionaron significativamente con las puntuaciones del SGRQ. Se observaron correlaciones significativas entre las dimensiones del cuestionario y las variables respiratorias y nutricionales que pretendían medir y permitió diferenciar adecuadamente los distintos grados de gravedad en función de los parámetros respiratorios evaluados. La desnutrición y la malabsorción condicionaron significativamente peores puntuaciones sólo en algunos dominios relacionados (como problemas con el peso). El efecto suelo fue menor al 15% en todas las dimensiones y el efecto techo fue elevado en 7 dimensiones.

Conclusiones

El cuestionario CFQR 14+ Spain es válido y fiable para su aplicación en España, aunque podría ser mejorado en algunas de las subescalas.

Palabras clave:
Calidad de vida
CFQR 14+
Fibrosis quística
Función pulmonar
Reagudizaciones
Tomografía computerizada de alta resolución
Prueba de la marcha de 6 minutos
Índice de masa corporal
Índice de masa magra
Diabetes
Full text is only aviable in PDF
References
[1.]
G. Olveira, C. Olveira.
Nutrición, fibrosis quística y aparato digestivo.
Nutr Hosp, 23 (2008), pp. 71-86
[2.]
J. Abbott.
Health-related quality of life measurement in cystic fibrosis: advances and limitations.
Chron Respir Dis, 6 (2009), pp. 31-41
[3.]
A. Padilla, G. Olveira, C. Olveira, A. Dorado, A.J. Plata, I. Gaspar, et al.
Utilidad del Cuestionario Respiratorio de St. George en población adulta con Fibrosis Quística.
Arch Bronconeumol, 43 (2007), pp. 205-211
[4.]
A.L. Quittner, A. Buu, M.A. Messer, A.C. Modi, M. Watrous.
Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.
Chest, 128 (2005), pp. 2347-2354
[5.]
B. Henry, P. Aussage, C. Grosskopf, J.M. Goehrs.
Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.
Qual Life Res, 12 (2003), pp. 63-76
[6.]
B. Henry, D. Staab, C. Prados, P. Aussge, S. de Ponth-brune, C. Grosskoptf, et al.
How to measure quality of life in cystic fibrosis (CF) patients across countries and cultures: The Cystic Fibrosis Questionnaire (CFQ) [abstract].
Pediatr Pulmonol, 17 (1998), pp. 392-393
[7.]
A.L. Quittner, S. Sweeny, M. Watrous, P. Munzenberger, K. Bearss, A. Gibson Nitza, et al.
Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis.
J Pediatr Psychol, 25 (2000), pp. 403-414
[8.]
V. Bregnballe, M. Thastum, L.D. Lund, C.R. Hansen, T. Preissler, P.O. Schiøtz.
Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14+).
J Cyst Fibros, 7 (2008), pp. 531-536
[9.]
P.H. Klijn, H.F. Van Stel, A.L. Quittner, J. Van der Net, W. Doeleman, C.P. Van der Schans, et al.
Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults.
J Cyst Fibros, 3 (2004), pp. 29-36
[10.]
T. Rozov, M.T. Cunha, O. Nascimento, A.L. Quittner, J.R. Jardim.
Linguistic validation of cystic fibrosis quality of life questionnaires.
J Pediatr (Rio J), 82 (2006), pp. 151-156
[11.]
K. Wenninger, P. Aussage, U. Wahn, D. Staab, German Cystic Fibrosis Questionnaire study group.
The revised German Cystic Fibrosis Quiestionnaire: Validation of a disease-specific health-related quality of life instrument.
Quality of Life Research, 12 (2003), pp. 77-85
[12.]
A.L. Quittner, C. Zapata, C. Landon.
Spanish translation of the Cystic Fibrosis Questionnaire: preliminary results of the cognitive testing phase [abstract].
Pediatr Pulmonol, 24 (2002), pp. 350
[13.]
B.J. Rosenstein, G.R. Cutting.
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.
J Pediatr, 132 (1998), pp. 589-595
[14.]
J. Roca, J. Sanchis, A. Agustí Vidal, F. Segarra, D. Navajas, R. Rodriguez-Roisin, et al.
Spirometric reference values for a Mediterranean population.
Bull Eur Physiopathol Respir, 18 (1986), pp. 101-102
[15.]
M. Bhalla, N. Turcios, V. Aponte, M. Jenkins, B.S. Leitman, D.I. McCauley, et al.
Cystic Fibrosis: Scoring System with thin-section CT.
Radiology, 179 (1991), pp. 783-788
[16.]
Vilaró J. Prueba de marcha de 6min. In: Burgos F, Casan P, editores. Procedimientos de evaluación de la función pulmonar II. Manual SEPAR de Procedimientos no 4. Madrid: Luzán 5; 2004. Pag:100–114. Available from: http://www.separ.es/publicaciones/procedimientos.Aspx.
[17.]
E. Kerem, S. Conway, S. Elborn, H. Heijerman.
Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus.
J Cystic Fibros, 4 (2005), pp. 7-26
[18.]
M. Vendrell, J. De Gracia, C. Olveira, M.A. Martinez, R. Girón, L. Máiz, et al.
Normativa SEPAR: diagnóstico y tratamiento de las bronquiectasias.
Arch Bronconeumol, 44 (2008), pp. 629-640
[19.]
J.V. Durnin, J. Womersley.
Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.
Br J Nutr, 32 (1974), pp. 77-97
[20.]
W.E. Siri.
Body composition from fluid spaces and density: analysis of methods.
Techniques for measuring body composition, pp. 223-244
[21.]
E.C. Creutzberg, E.F.M. Wouters, R. Mostert, C.A.P.M. Weling-Scheepers, A.M.W.J. Schols.
Efficacy of Nutritional Supplementation Therapy in Depleted Patients With Chronic Obstructive Pulmonary Disease.
Nutrition, 19 (2003), pp. 120-127
[22.]
A. Picarelli, M. Greco, F. Di Giovambattista, A. Ramazzotti, C. Cedrone, E. Corazziari, et al.
Quantitative determination of faecal fat, nitrogen and water by means of a spectrophotometric technique: near infrared reflectance analysis (NIRA). Assessment of its accuracy and reproducibility compared with chemical methods.
Clin Chim Acta, 234 (1995), pp. 147-156
[23.]
G. Olveira, C. Olveira, E. Casado-Miranda, A. Padilla, A. Dorado, G. Rojo, et al.
Markers for the validation of reported dietary intake in adults with cystic fibrosis.
J Am Diet Assoc, 109 (2009), pp. 1704-1711
[24.]
J.M. Valderas, M. Ferrer, J. Alonso.
Health-related quality of life instruments and other patient-reported outcomes.
Med Clin (Barc)., 125 (2005), pp. 56-60
[25.]
E. Kerem, J. Reisman, M. Corey, G.J. Canny, H. Levison.
Prediction of mortality in patients with cystic fibrosis.
N Engl J Med, 326 (1992), pp. 1187-1191
[26.]
M.A. Martínez-García, M. Perpiñá Tordera, P. Román Sánchez, J.J. Soler Cataluña.
Internal consistency and validity of the Spanish version of the St. George's respiratory questionnaire for use in patients with clinically stable bronchiectasis.
Arch Bronconeumol, 41 (2005), pp. 110-117
[27.]
M.A. Martínez-García, M. Perpiñá-Tordera, P. Román-Sánchez, J.J. Soler-Cataluña.
Quality-of-life determinants in patients with clinically stable bronchiectasis.
Chest, 128 (2005), pp. 739-745
[28.]
A.A. Ionescu, L.S. Nixon, S. Luzio, V. Lewis-Jenkins, W.D. Evans, M.D. Stone, et al.
Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis.
Am J Respir Crit Care Med, 165 (2002), pp. 495-500
[29.]
M.A. Martínez-García, M. Perpiñá-Tordera, P. Román-Sánchez, J.J. Soler-Cataluña, A. Carratalá, M. Yago, et al.
The association between bronchiectasis, sistemic inflammation and Tumor Necrosis Factor alpha.
Arch Bronconeumol, 44 (2008), pp. 8-14
[30.]
S. Enrigth, K. Chatham, A.A. Ionescu, V.B. Unnithan, D.J. Shale.
The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis.
J Cyst Fibros, 6 (2007), pp. 384-390
[31.]
C. Olveira-Fuster, G. Olveira-Fuster, A. Dorado-Galindo, A. Padilla-Galo, J. Merino-Berdugo, F. Miralles-Lozano.
Gasto energético en sujetos adultos con Fibrosis Quística (FQ): concordancia entre la calorimetría indirecta y diferentes fórmulas estimativas.
Arch Bronconeumol, 43 (2007), pp. 366-372
[32.]
B.W. Ramsey, P.M. Farrel, P. Pencharz.
Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee.
Am J Clin Nutr, 55 (1992),
[33.]
G. Olveira, A. Dorado, C. Olveira, A. Padilla, G. Rojo-Martínez, E. García-Escobar, et al.
Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis.
Br J Nutr, 96 (2006), pp. 343-349
[34.]
A. Quittner, A. Buu, M. Davis, A. Modi.
Application of factor analysis and random effects modeling to examine gender differences in HRQOL.
Qual Life Res, 11 (2002), pp. 661
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?